These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14581896)

  • 1. A case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy.
    Jakub JW; Drake FD; Pippas AW; Gardner M; Fraile RJ; Giuliano R; Pendas S; Reintgen DS
    Cancer Control; 2003; 10(5):411-3. PubMed ID: 14581896
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathological correlation of cutaneous metastatic breast carcinoma using lymphatic and vascular markers: lymphatics are mainly involved in cutaneous metastasis.
    Yun SJ; Park HY; Lee JS; Park MH; Lee JB; Won YH
    Clin Exp Dermatol; 2012 Oct; 37(7):744-8. PubMed ID: 22329727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of routine pathological assessment of breast cancer].
    Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):5-7. PubMed ID: 19489217
    [No Abstract]   [Full Text] [Related]  

  • 4. Microvessel and lymphatic density in tubular carcinoma of the breast: comparative study with invasive low-grade ductal carcinoma.
    Fernandez-Aguilar S; Jondet M; Simonart T; Nöel JC
    Breast; 2006 Dec; 15(6):782-5. PubMed ID: 16931017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
    Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
    Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the intra-vessel tumor characteristics of invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Sasaki S; Imoto S; Ochiai A
    Virchows Arch; 2004 Jan; 444(1):20-7. PubMed ID: 14624360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contralateral axillary drainage in breast tumor recurrence].
    Sabaté M; Roca I; Córdoba O; Kysiel N; Rubio I; Castell J
    Rev Esp Med Nucl; 2011; 30(5):327-8. PubMed ID: 21514976
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
    Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
    Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular infiltration in the tumor bed is a useful marker of biological behavior in breast cancer.
    Panagiotopoulos N; Lagoudianakis E; Pappas A; Filis K; Salemis N; Manouras A; Kontzoglou K; Zografos G
    J BUON; 2016; 21(5):1082-1089. PubMed ID: 27837608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic vessel assessment by podoplanin (D2-40) immunohistochemistry in breast cancer.
    Wahal SP; Goel MM; Mehrotra R
    J Cancer Res Ther; 2015; 11(4):798-804. PubMed ID: 26881521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.
    Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
    Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
    Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
    Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
    Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
    Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
    Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma erysipeloides associated with breast carcinoma.
    Vega Gutiérrez J; Rodríguez MA
    Int J Dermatol; 2007 Jun; 46(6):613-4. PubMed ID: 17550562
    [No Abstract]   [Full Text] [Related]  

  • 16. Submental lymph node metastasis from invasive ductal breast carcinoma.
    Al-Benna S; Tzakas E
    Arch Gynecol Obstet; 2012 Apr; 285(4):1153-6. PubMed ID: 21904855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast neoplasms: histological classification].
    Sakamoto G
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():54-9. PubMed ID: 17682139
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
    Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
    Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsy in invasive breast cancer and ductal carcinoma in situ.
    Echenique MM; Cangiano J
    Bol Asoc Med P R; 2003; 95(2):23-4, 29. PubMed ID: 14531197
    [No Abstract]   [Full Text] [Related]  

  • 20. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma.
    Acs G; Esposito NN; Rakosy Z; Laronga C; Zhang PJ
    Am J Surg Pathol; 2010 Nov; 34(11):1637-46. PubMed ID: 20975342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.